ARTICLE | Clinical News
Diovan valsartan cardiovascular data
September 12, 2005 7:00 AM UTC
Data from the Val-HeFT trial in 5,010 heart failure patients showed that beneficial effects of Diovan in reducing mortality and morbidity were not significantly different in the presence of renal dysf...